Nyfosa AB (2JM) Financial Statements
Nyfosa AB Financial Overview
Nyfosa AB's market cap is currently $1.37B. The company's EPS TTM is $6.07; its P/E ratio is 12.86; and it has a dividend yield of 3.71%. Nyfosa AB is estimated to report earnings on February 8, 2027, and the estimated EPS forecast is $0.18. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.60B | $ 3.67B | $ 3.56B | $ 3.15B | $ 2.46B |
| Gross Profit | $ 2.52B | $ 2.54B | $ 2.45B | $ 2.09B | $ 1.65B |
| Operating Income | $ 2.33B | $ 2.37B | $ 2.26B | $ 1.95B | $ 1.53B |
| EBITDA | $ 1.88B | $ 1.52B | $ 2.27B | $ 2.54B | $ 4.08B |
| Net Income | $ 542.00M | $ 114.00M | $ -639.00M | $ 1.69B | $ 3.11B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 123.00M | $ 451.00M | $ 435.00M | $ 691.00M | $ 534.00M |
| Total Assets | $ 42.40B | $ 43.33B | $ 43.68B | $ 45.34B | $ 40.63B |
| Total Debt | $ 21.60B | $ 21.91B | $ 23.85B | $ 24.52B | $ 21.27B |
| Net Debt | $ 21.47B | $ 21.45B | $ 23.42B | $ 23.83B | $ 20.74B |
| Total Liabilities | $ 24.71B | $ 24.71B | $ 26.75B | $ 26.92B | $ 23.36B |
| Stockholders' Equity | $ 17.69B | $ 18.58B | $ 16.88B | $ 18.38B | $ 17.24B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.34B | $ 1.39B | $ 1.54B | $ 5.00B | $ 7.41B |
| Operating Cash Flow | $ 1.35B | $ 1.39B | $ 1.54B | $ 1.64B | $ 1.39B |
| Investing Cash Flow | $ -705.00M | $ -602.00M | $ -284.00M | $ -3.39B | $ -6.05B |
| Financing Cash Flow | $ -964.00M | $ -779.00M | $ -1.51B | $ 1.89B | $ 4.88B |
Currency in SEK